In rodent models of systemic inflammation, atherosclerosis, and non-alcoholic steatohepatitis (NASH), PPARα exerts negative regulation on pro-inflammatory and acute phase response signaling pathways [60,61]. This evidence concerns the gene PPARA and metabolic dysfunction-associated steatohepatitis.